Evolus, Inc. (EOLS)
7.89
-0.68
(-7.93%)
USD |
NASDAQ |
Sep 10, 15:22
Evolus EPS Diluted (Quarterly) : -0.1221 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1221 |
| March 31, 2026 | -0.1638 |
| December 31, 2025 | 0.002 |
| September 30, 2025 | -0.2431 |
| June 30, 2025 | -0.2656 |
| March 31, 2025 | -0.2966 |
| December 31, 2024 | -0.1072 |
| September 30, 2024 | -0.3036 |
| June 30, 2024 | -0.181 |
| March 31, 2024 | -0.223 |
| December 31, 2023 | -0.2067 |
| September 30, 2023 | -0.2968 |
| June 30, 2023 | -0.3187 |
| March 31, 2023 | -0.2619 |
| December 31, 2022 | -0.234 |
| September 30, 2022 | -0.3609 |
| June 30, 2022 | -0.4185 |
| March 31, 2022 | -0.314 |
| December 31, 2021 | -0.3271 |
| September 30, 2021 | -0.3533 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.305 |
| March 31, 2021 | 0.1557 |
| December 31, 2020 | -3.280 |
| September 30, 2020 | -0.3395 |
| June 30, 2020 | -0.6262 |
| March 31, 2020 | -0.5853 |
| December 31, 2019 | -0.4724 |
| September 30, 2019 | -0.9823 |
| June 30, 2019 | -1.371 |
| March 31, 2019 | -0.4016 |
| December 31, 2018 | -0.4553 |
| September 30, 2018 | -0.4776 |
| June 30, 2018 | -0.69 |
| March 31, 2018 | -0.3046 |
| December 31, 2017 | 0.24 |
| September 30, 2017 | -0.1082 |
| June 30, 2017 | -0.14 |
| March 31, 2017 | -0.1691 |
| December 31, 2016 | -0.1538 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.052M |
| Revenue (Quarterly) | 84.08M |
| Total Expenses (Quarterly) | 92.14M |
| Enterprise Value | 685.37M |
| Gross Profit Margin (Quarterly) | 66.18% |
| Profit Margin (Quarterly) | -9.58% |
| Earnings Yield | -6.68% |
| Normalized Earnings Yield | -6.943 |